CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loi, S.
Right arrow Articles by Phillips, K.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loi, S.
Right arrow Articles by Phillips, K.-A.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1686-1691, July 2005
© 2005 American Association for Cancer Research

Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer

Sherene Loi1, Roger L. Milne2, Michael L. Friedlander4, Margaret R.E. McCredie5, Graham G. Giles3, John L. Hopper2 and Kelly-Anne Phillips1

1 Peter MacCallum Cancer Centre; 2 The University of Melbourne; 3 The Cancer Council Victoria, Victoria, Australia; 4 Prince of Wales Hospital, New South Wales, Australia; and 5 The University of Otago, Dunedin, New Zealand

Requests for reprints: John Hopper, Department of Public Health, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, 723 Swanston Street, Carlton, Victoria 3053, Australia. Phone: 61-3-8344-0697; Fax: 61-3-9349-5815. E-mail: j.hopper{at}unimelb.edu.au

Purpose: Obesity is associated with adverse outcomes in postmenopausal women with breast cancer. In premenopausal women, the association is less clear.

Methods: A population-based sample of 1,360 Australian women with breast cancer before the age of 60 years, 47% diagnosed before age 40, and 74% premenopausal, was studied prospectively for a median of 5 years (range, 0.2-10.8 years). Obesity was defined as a body mass index of ≥30 kg/m2. The hazard ratio (HR) for adverse clinical outcome associated with obesity was estimated using Cox proportional hazard survival models.

Results: Obesity increased with age (P < 0.001) and was associated with increased breast cancer recurrence (P = 0.02) and death (P = 0.06), larger tumors (P = 0.002), and more involved axillary nodes (P = 0.003) but not with hormone receptor status (P ≥ 0.6) or with first cycle adjuvant chemotherapy dose reductions (P = 0.1). Adjusting for number of axillary nodes, age at diagnosis, tumor size, grade, and hormone receptor status, obese women of all ages were more likely than nonobese women to have disease recurrence [HR, 1.57; 95% confidence interval (95% CI), 1.11-2.22; P = 0.02] and to die from any cause during follow-up (HR, 1.56; 95% CI, 1.01-2.40; P = 0.05). In premenopausal women, the adjusted HRs were 1.50 (95% CI, 1.00-2.26; P = 0.06) and 1.71 (95% CI, 1.05-2.77; P = 0.04), respectively.

Conclusions: Obesity is independently associated with poorer outcomes in premenopausal women, as it is in postmenopausal women, and this is not entirely explained by differences in tumor size or nodal status. Given the high and increasing prevalence of obesity in western countries, more research on improving the treatment of obese breast cancer patients is warranted.




This article has been cited by other articles:


Home page
JCOHome page
J. K. Litton, A. M. Gonzalez-Angulo, C. L. Warneke, A. U. Buzdar, S.-W. Kau, M. Bondy, S. Mahabir, G. N. Hortobagyi, and A. M. Brewster
Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer
J. Clin. Oncol., September 1, 2008; 26(25): 4072 - 4077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. J. Cleveland, S. M. Eng, P. E. Abrahamson, J. A. Britton, S. L. Teitelbaum, A. I. Neugut, and M. D. Gammon
Weight Gain Prior to Diagnosis and Survival from Breast Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1803 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. W. Reeves, K. Faulkner, F. Modugno, T. A. Hillier, D. C. Bauer, K. E. Ensrud, J. A. Cauley, and for the Study of Osteoporotic Fractures Research G
Body Mass Index and Mortality among Older Breast Cancer Survivors in the Study of Osteoporotic Fractures
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1468 - 1473.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-Wahnefried, B. Grant, A. McTiernan, C. L. Rock, C. Thompson, T. Gansler, et al.
Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices
CA Cancer J Clin, November 1, 2006; 56(6): 323 - 353.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. E. Abrahamson, M. D. Gammon, M. J. Lund, E. W. Flagg, P. L. Porter, J. Stevens, C. A. Swanson, L. A. Brinton, J. W. Eley, and R. J. Coates
General and Abdominal Obesity and Survival among Young Women with Breast Cancer.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1871 - 1877.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.